News

“We all want to grow Kentucky’s tech sector and create the high-paying, knowledge-based jobs that follow. A big part of doing so is turning Kentucky’s own academic research and development capabilities into commercially viable products and startups.”

KYNETIC, funded by the National Institutes of Health (NIH), is excited to announce that five of the seven projects recently awarded $50,000 to bring their innovations toward product development are from the University of Kentucky.

This student-nominated award recognizes UK faculty members who demonstrate an outstanding commitment to mentoring undergraduate researchers, providing exceptional undergraduate research experiences, as well as supporting and promoting the undergraduate research initiatives on campus.

“The Appalachian Center is thrilled to support these student researchers that represent nine departments across four colleges. We look forward to learning from their work as they continue to produce cutting-edge research in and on the region.”

Any full-time UK undergraduate student of any major who has completed at least one semester of research with a faculty mentor is eligible to apply for a Summer Research Fellowship.

Brent Seales, professor and chair of the Department of Computer Science at UK, is considered the foremost expert in the digital restoration of damaged and unreadable manuscripts. To this day, his quest to uncover the wisdom of the ancients is ever evolving.

Dutch is leading the College of Medicine’s COVID-19 Unified Research Experts (CURE) Alliance team, which brings together faculty expertise from multiple disciplines across the university to focus on advising COVID-19 patient care and clinical trials based on emerging research.

Supported by XLerateHealth, a health care startup accelerator in Louisville, Kentucky, and by UK, EnRICH is an outgrowth of NIH funding UK received in October 2018 — $3.5 million over three years — to create the XLerator Network.

The National Institutes of Health award will fund ongoing research led by UK Neuroscience and Spinal Cord and Brain Injury Research Center (SCoBIRC) Professor Patrick Sullivan, Ph.D., who has studied the effects of the experimental drug MP201 on TBI.

This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping it will ultimately help prevent Alzheimer’s disease.